Position in AMGN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,087,446
+$20,285 QoQ
Shares Held
3,003
-1.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,648
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PITTENGER & ANDERSON INC holds $56,834,770 across 10 Drug Manufacturers - General names. AMGN ranks #7 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
103,992 | $26,410,848 | |
| 2 | NVS |
Novartis AG
|
49,020 | $7,682,414 | |
| 3 | ABBV |
AbbVie Inc.
|
29,986 | $7,545,677 | |
| 4 | MRK |
Merck & Co., Inc.
|
50,965 | $6,549,002 | |
| 5 | AZN |
Astrazeneca PLC
|
32,459 | $6,154,875 | |
| 6 | LLY |
ELI LILLY & Co
|
1,077 | $1,291,786 | |
| 7 | AMGN |
Amgen Inc
This page
|
3,003 | $1,087,446 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,849 | $106,539 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,087,446 | 3,003 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $1,067,161 | 3,033 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $973,092 | 2,973 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $813,582 | 2,883 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $798,540 | 2,860 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $766,413 | 2,460 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $641,174 | 2,460 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $792,636 | 2,460 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $768,627 | 2,460 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $699,427 | 2,460 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $708,529 | 2,460 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $661,149 | 2,460 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $612,775 | 2,760 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $667,230 | 2,760 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $724,886 | 2,760 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $622,104 | 2,760 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $671,508 | 2,760 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $670,808 | 2,774 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $972,995 | 4,325 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $8,145,983 | 38,307 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $9,474,806 | 38,871 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $9,601,577 | 38,590 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $8,262,864 | 35,938 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $9,029,542 | 35,527 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $8,251,326 | 34,984 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $7,017,904 | 34,617 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||